celecoxib has been researched along with pasireotide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Tang, CW; Wang, CH; Xie, Y | 1 |
1 other study(ies) available for celecoxib and pasireotide
Article | Year |
---|---|
SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Celecoxib; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Down-Regulation; Drug Synergism; Hep G2 Cells; Humans; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Necrosis; Pyrazoles; Receptors, Somatostatin; Somatostatin; Sulfonamides; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |